Dr. Tanoue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
New York, NY 10021Phone+1 212-746-4748Fax+1 212-746-6692
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2016 - 2019
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
Creighton University School of MedicineClass of 2013
Certifications & Licensure
HI State Medical License 2019 - 2026
CA State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 14 citationsRelationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE studyMichael T. Tanoue, Sverre E. Kjeldsen, Richard B. Devereux, Peter M. Okin
Blood Pressure. 2017-03-04 - 4 citationsRelationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophyMichael T. Tanoue, Sverre E. Kjeldsen, Richard B. Devereux, Peter M. Okin
Blood Pressure. 2016-05-05 - 1 citations#Cardioonc: Are We Reaching Across the Digital Aisle?Samuel B. Jackson, Michael Tanoue, Negeen Shahandeh, Juan Lopez-Mattei, Sherry-Ann Brown
JACC. Cardiooncology. 2021-09-01
Authored Content
- Impact of Ticagrelor in Patients with Prior MI and MVD for Reducing Cardiovascular EventsJanuary 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
